Magata Yasuhiro

2021 - 2024 Basic research for development of a new drug for the treatment of myasthenia gravis

2020 - 2023 がん悪液質における中枢機能障害の画像科学による病態機能解明

2020 - 2023 セロトニン-オキシトシン相互作用の多角的検討:自閉症中核症状の治療シーズ創出

2019 - 2022 ニコチン受容体機能に着目した注意欠如・多動症の病態解明

2019 - 2022 統合失調症者における喫煙の自己治療作用へのα7ニコチン性受容体と神経炎症の関与

2019 - 2022 Development of perforin imaging probe for early evaluation of ICI treatment

2019 - 2022 Development of Molecular Targeted Imaging for Prediction of Radiotherapy Effectiveness: Based on DNA Repair Mechanisms

2018 - 2021 Establishment of Nuclear Medicine Diagnostic Method to Evaluate Drug Metabolizing Enzyme Activity for Personalized Pharmacotherapy Optimization

2018 - 2021 Development of discrimination between mono-polar and bipolar depression by utilizing positron emission tomography with serotonergic triple tracers

2018 - 2021 Positron emmission tomography study of dopamine release by subthalamic nucleus and pallidal stimulation in Parkinson's diseae model rats.

2017 - 2020 Development of non-invasive imaging of tissue fibrosis

2016 - 2020 Development of new therapy using 2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPO) for acute lung injury

2016 - 2019 Theranostics by combination with nuclear and optical methods

2016 - 2019 Development of molecular target imaging method targeting DNA repair mechanism-aiming at radiation treatment effect prediction-

2016 - 2019 Alpha 7 nicotinic acetylcholine receptors availability in schizophrenia: A PET study

2016 - 2019 An alpha7 nicotinic acetylcholine receptor in anorexia nervosa

2014 - 2018 A study of dopamine release in Parkinson'disease-deep brain stimulation model rat by using PET scan

2014 - 2017 In vivo imaging study for the timing of neurogenesis and neuroinflammation altered in Alzheimer's disease

2014 - 2017 自閉症の脳内ニコチン様アセチルコリン受容体:PETによる研究

2014 - 2017 Development of a PET organic imaging probe to visualize metal related reaction in vivo

2013 - 2017 Development of a molecular targeted radiolabeled diagnostic agent useful for personalized drug therapy of psychoneurotic diseases

2013 - 2016 development of a novel imaging probe for alteration of mitochondria function based on cancer therapy

2012 - 2016 Effects of parameters of the Deep brain stimulation on the therapeutic efficacy in MPTP treated monkey, a PET study

2011 - 2014 In vivo imaging of the activity of ganma-secretase for amyloid production in Alzheimer's disease

2012 - 2013 画像解析に基づくtissue dysoxia治療の実験的検討

2011 - 2012 Establishments of in vivo imaging technique for functional visualization ofadipose tissue and its potential application for diagnosis.

2011 - 2012 Development of molecular target radiation therapy from molecular target imaging

2010 - 2012 development of a novel imaging method for cancer therapy based on alteration of mitochondriafunction

2009 - 2011 Synthesis of a novel imaging agent aimed for preclinical diagnosis

2009 - 2011 Development of radiogallium-labeled agents for PET imaging without cyclotron

2009 - 2011 Development of novel CT contrast agents with long retention in the vessel

2009 - 2011 Elucidation of biological basis of autism as fatty acid metabolic disease

2008 - 2011 Development of novel radiopharmaceuticals for diagnosis of cerebral neurodegeneration and functional recovery after intrastriatal grafts/gene therapy

2006 - 2007 An experimental studyonimage analysis and resuscitation of tissue dysoxia

2005 - 2007 Development of novel evaluation system and radiopharmaceutical for prediction of tumor treatment effect ; especially oxygen effect of tumor therapy

2005 - 2007 Studies on radiopharmaceuticals with mitochondria membrane potential dependent tumor accumulation

2005 - 2007 DEVELOPMENT OF NOVEL RADIOPHARMACEUTICALS FOR EARLY STAGE DIAGNOSIS OF CEREBRAL NEURODEGENERATION AND FUNCTIONAL RECOVERRY AFTER INTRASTRIATAL GRAFTS

2005 - 2006 統合失調症の定量的評価を目的とする分子イメージング法の開発研究

2004 - 2005 An experimental study on resuscitation of tissue dysoxia

2002 - 2004 DEVELOPMENT OF NOVEL RADIOPHARMACEUTICALS FOR EARLY STAGE DIAGNOSIS OF CEREBRAL NEURODEGENERATION.

2002 - 2003 Development of Tc-99m labeled long chain fatty acid derivative for myocardial imaging.

2001 - 2003 The study for imaging, in vivo, brain mitochondrial. dysfunction using positron emission tomography

2001 - 2003 Development of a radioiodinated lipophilic cation as a new SPECT radiopharmaceutical for cancer diagnosis.

2001 - 2002 二官能性キレートによる放射性レニウム骨腫瘍治療薬剤の開発

2000 - 2001 Development of Tc-99m labeled long chain fatty acid derivative for myocardial imaging

2000 - 2001 Development of in vivo dynamic and noninvasive imaging methodology of neurotransmission system with optically active radioligand.

1998 - 1999 Development of Radioiodinated Glucose Derivative to Evaluate Energy Metabolism in vivo with SPECT

1998 - 1999 Development of optically active radioligand for biomedical imaging of neurotrasmission

1998 - 1998 高感度放射性機能探索分子の開発とそれによる神経受容体機能の画像解析

1997 - 1998 新しい心臓核医学的手法を用いた糖尿病性心臓障害の病態解明と早期診断への臨床応用

1997 - 1998 Development of quantitative autoradiographic method for assessing fuctional imaging in living brain slices.

1996 - 1996 糖代謝機能診断を目的とするSPECT用放射性薬品の開発に関する研究

1995 - 1995 糖代謝機能診断を目的とするSPECT用放射性薬品の開発に関する研究

1995 - 1995 SPECTによる脳受容体機能の定量的解析法の研究

1995 - 1995 ポジトロンCTによる心筋脂肪酸、ブドウ糖および酸素代謝に関する研究

1994 - 1994 ポジトロンCTによる心筋局所の糖および酸素代謝に関する研究

1993 - 1993 ニコチン様アセチルコリン受容体機能の核医学診断法確立に関する研究

1992 - 1993 Noninvasive studies of higher brain functions related to voluntary movement

1992 - 1992 ポジトロンCTを用いた心筋局所の嫌気性・好気性糖代謝の研究

1991 - 1992 Studies on Non-invasive Measurement of Integrative Higher Brain Function and Disorders.

1990 - 1990 ポジトロンCTを用いた心筋局所の酸素代謝の解析

1989 - 1990 Development of a New Methodology for Pancreatic Diagnosis in Nuclear Medicine.